{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:23:10Z","timestamp":1793730190705,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003969","name":"Ministry of Health and Medical Education","doi-asserted-by":"publisher","award":["700\/120"],"award-info":[{"award-number":["700\/120"]}],"id":[{"id":"10.13039\/501100003969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005756","name":"Shahrekord University of Medical Sciences","doi-asserted-by":"publisher","award":["2763"],"award-info":[{"award-number":["2763"]}],"id":[{"id":"10.13039\/501100005756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005756","name":"Shahrekord University of Medical Sciences","doi-asserted-by":"publisher","award":["3366"],"award-info":[{"award-number":["3366"]}],"id":[{"id":"10.13039\/501100005756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Comorbidities are common in chronic obstructive pulmonary disease (COPD) patients. This study was conducted to determine the prevalence of common comorbidities in patients with COPD compared with people without COPD. This cross-sectional, population-based study was performed on 6961 adults aged 35\u201370\u00a0years enrolled in the Shahrekord PERSIAN\u00a0cohort study. Data (demographic and clinical characteristics, comorbidities, anthropometric and blood pressure measurements, laboratory, and spirometry tests) collection was performed according to the cohort protocol from 2015 to 2019. In the present study, 215 (3.1%) patients were diagnosed with COPD and 1753 (25.18%) ones with restrictive lung patterns. The mean age of COPD patients was 52.5\u2009\u00b1\u20099.76\u00a0years. 55.8% of patients were male, 17.7% were current smokers and 12.1% had a history of smoking or were former smokers. 5.6% of patients had no comorbidity and 94.5% had at least one comorbidity. The most common comorbidities in COPD patients were dyslipidemia (70.2%), hypertension (30.2%), metabolic syndrome (22.8%), and diabetes (16.7%). The most common comorbidities in individuals with a restrictive spirometry pattern were dyslipidemia (68.9%), metabolic syndrome (27.2%), hypertension (26.1%), depression (17.6%), and fatty liver (15.5%). The logistic regression analysis with 95% confidence interval (95%CI) of odds ratio (OR) showed that comorbidities of chronic lung diseases (OR\u2009=\u20092.12, 95% CI 1.30\u20133.44), diabetes (OR\u2009=\u20091.54, 95%CI 1.03\u20132.29), cardiovascular disease (OR\u2009=\u20091.52, 95%CI 1.17\u20132.43), and hypertension (OR\u2009=\u20091.4, 95%CI 1.02\u20131.99) were more likely to occur in COPD patients than in healthy individuals. Knowing these prevalence rates and related information provides new insights on comorbidities to reduce disease burden and develop preventive interventions and to regulate health care resources to meet the needs of patients in primary health care.<\/jats:p>","DOI":"10.1038\/s41598-020-79707-y","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T11:02:30Z","timestamp":1610708550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN\u00a0cohort study in southwest Iran"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8790-6910","authenticated-orcid":false,"given":"Fatemeh Zeynab","family":"Kiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1588-2136","authenticated-orcid":false,"given":"Ali","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"79707_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/15412555.2012.744963","volume":"10","author":"N Putcha","year":"2013","unstructured":"Putcha, N., Puhan, M. A., Hansel, N. N., Drummond, M. B. & Boyd, C. M. Impact of co-morbidities on self-rated health in self-reported COPD: An analysis of NHANES 2001\u20132008. COPD J. Chronic Obstruct. Pulm. Dis. 10, 324\u2013332 (2013).","journal-title":"COPD J. Chronic Obstruct. Pulm. Dis."},{"key":"79707_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3889\/oamjms.2016.060","volume":"4","author":"J Stojkovikj","year":"2016","unstructured":"Stojkovikj, J. et al. The prevalence of diabetes mellitus in COPD patients with severe and very severe stage of the disease. Open Access Maced J. Med. Sci. 4, 253 (2016).","journal-title":"Open Access Maced J. Med. Sci."},{"key":"79707_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","volume":"195","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier, C. F. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am. J. Respir. Crit. Care Med. 195, 557\u2013582 (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"79707_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1183\/09059180.00008612","volume":"22","author":"A Cavaill\u00e8s","year":"2013","unstructured":"Cavaill\u00e8s, A. et al. Comorbidities of COPD. Eur. Respir. Rev. J. 22, 454\u2013475 (2013).","journal-title":"Eur. Respir. Rev. J."},{"key":"79707_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2147\/COPD.S49621","volume":"9","author":"MC Smith","year":"2014","unstructured":"Smith, M. C. & Wrobel, J. P. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int. J. Chronic Obstruct. Pulm. Dis. 9, 871 (2014).","journal-title":"Int. J. Chronic Obstruct. Pulm. Dis."},{"key":"79707_CR6","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.4187\/respcare.03788","volume":"60","author":"M Ajmera","year":"2015","unstructured":"Ajmera, M. et al. Multimorbidity and COPD medication receipt among Medicaid beneficiaries with newly diagnosed COPD. Respir. Care 60, 1592\u20131560 (2015).","journal-title":"Respir. Care"},{"key":"79707_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2049-6958-10-4","volume":"10","author":"G Fumagalli","year":"2015","unstructured":"Fumagalli, G. et al. INDACO project: COPD and link between comorbidities, lung function and inhalation therapy. Multidiscip. Respir. Med. 10, 4 (2015).","journal-title":"Multidiscip. Respir. Med."},{"key":"79707_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","volume":"5","author":"JB Soriano","year":"2017","unstructured":"Soriano, J. B. et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir. Med. 5, 691\u2013706 (2017).","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"79707_CR9","first-page":"113","volume":"22","author":"MJ Divo","year":"2016","unstructured":"Divo, M. J. et al. Chronic obstructive pulmonary disease comorbidities network. Eur. Respir. J. 22(2), 113\u2013118 (2016).","journal-title":"Eur. Respir. J."},{"key":"79707_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.resinv.2016.07.001","volume":"54","author":"A Corlateanu","year":"2016","unstructured":"Corlateanu, A., Covantev, S., Mathioudakis, A. G., Botnaru, V. & Siafakas, N. Prevalence and burden of comorbidities in chronic obstructive pulmonary disease. Respir. Investig. 54, 387\u2013396 (2016).","journal-title":"Respir. Investig."},{"key":"79707_CR11","doi-asserted-by":"publisher","first-page":"e0194819","DOI":"10.1371\/journal.pone.0194819","volume":"13","author":"YF Gebreyes","year":"2018","unstructured":"Gebreyes, Y. F. et al. Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015. PLoS ONE 13, e0194819 (2018).","journal-title":"PLoS ONE"},{"key":"79707_CR12","doi-asserted-by":"publisher","first-page":"e6836","DOI":"10.1097\/MD.0000000000006836","volume":"96","author":"H-L Yin","year":"2017","unstructured":"Yin, H.-L. et al. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A meta-analysis. Medicine 96, e6836 (2017).","journal-title":"Medicine"},{"key":"79707_CR13","doi-asserted-by":"publisher","first-page":"1700917","DOI":"10.1183\/13993003.00917-2017","volume":"50","author":"JF van Boven","year":"2017","unstructured":"van Boven, J. F. Costly comorbidities of COPD: The ignored side of the coin?. Eur. Respir. Soc. 50, 1700917 (2017).","journal-title":"Eur. Respir. Soc."},{"key":"79707_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1164\/rccm.201207-1299OC","volume":"186","author":"P Lange","year":"2012","unstructured":"Lange, P. et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: A study of the general population. Am. J. Respir. Crit. Care Med. 186, 975\u2013981 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"79707_CR15","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.rmed.2015.05.015","volume":"109","author":"H Meteran","year":"2015","unstructured":"Meteran, H., Backer, V., Kyvik, K. O., Skytthe, A. & Thomsen, S. F. Comorbidity between chronic obstructive pulmonary disease and type 2 diabetes: A nation-wide cohort twin study. Respir. Med. 109, 1026\u20131030 (2015).","journal-title":"Respir. Med."},{"key":"79707_CR16","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1183\/09031936.00180812","volume":"41","author":"B Begh\u00e9","year":"2013","unstructured":"Begh\u00e9, B., Verduri, A., Roca, M. & Fabbri, L. M. Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD. Eur. Respir. J. 41, 993\u2013995 (2013).","journal-title":"Eur. Respir. J."},{"key":"79707_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo, J. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 187, 347\u2013365 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"79707_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12889-018-5364-2","volume":"18","author":"A Khaledifar","year":"2018","unstructured":"Khaledifar, A. et al. The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study. BMC Public Health 18, 660 (2018).","journal-title":"BMC Public Health"},{"key":"79707_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi, H. et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. Am. J. Epidemiol. 187, 647\u2013655 (2018).","journal-title":"Am. J. Epidemiol."},{"key":"79707_CR20","first-page":"91","volume":"3","author":"J Martin","year":"2008","unstructured":"Martin, J. Hypertension guidelines: Revisiting the JNC 7 recommendations. JLGH 3, 91\u201397 (2008).","journal-title":"JLGH"},{"key":"79707_CR21","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.2337\/diacare.28.suppl_1.S37","volume":"28","author":"AD Association","year":"2005","unstructured":"Association, A. D. Diagnosis and classification of diabetes mellitus. Diabetes Care 28, S37-42 (2005).","journal-title":"Diabetes Care"},{"key":"79707_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","volume":"109","author":"SM Grundy","year":"2004","unstructured":"Grundy, S. M., Brewer, H. B. Jr., Cleeman, J. I., Smith, S. C. Jr. & Lenfant, C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. Circulation 109, 433\u2013438 (2004).","journal-title":"Circulation"},{"key":"79707_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller, M. R. et al. Standardisation of spirometry. Eur. Respir. J. 26, 319\u2013338 (2005).","journal-title":"Eur. Respir. J."},{"key":"79707_CR24","doi-asserted-by":"publisher","first-page":"14008","DOI":"10.1038\/npjpcrm.2014.8","volume":"24","author":"LM Nagorni-Obradovic","year":"2014","unstructured":"Nagorni-Obradovic, L. M. & Vukovic, D. S. The prevalence of COPD co-morbidities in Serbia: Results of a national survey. NPJ. Primary Care Respir. Med. 24, 14008 (2014).","journal-title":"NPJ. Primary Care Respir. Med."},{"issue":"1","key":"79707_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/ijpvm.IJPVM_478_18","volume":"11","author":"H Sharifi","year":"2020","unstructured":"Sharifi, H. et al. Burden of obstructive lung disease in Iran: Prevalence and risk factors for COPD in North of Iran. Int. J. Prev. Med. 11(1), 78 (2020).","journal-title":"Int. J. Prev. Med."},{"key":"79707_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/lungindia.lungindia_129_18","volume":"36","author":"H Sharifi","year":"2019","unstructured":"Sharifi, H. et al. Burden of Obstructive Lung Disease study in Iran: First report of the prevalence and risk factors of COPD in five provinces. Lung India 36, 14 (2019).","journal-title":"Lung India"},{"issue":"3","key":"79707_CR27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1183\/09031936.00132011","volume":"41","author":"A Jithoo","year":"2012","unstructured":"Jithoo, A. et al. Case-finding options for COPD: Results from the BOLD Study. Eur. Respir. J. 41(3), 548\u2013555 (2012).","journal-title":"Eur. Respir. J."},{"key":"79707_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1617-9625-11-5","volume":"11","author":"S Hooman","year":"2013","unstructured":"Hooman, S., Zahra, H., Safa, M., Hassan, F. M. & Reza, M. M. Association between cigarette smoking and suicide in psychiatric inpatients. Tobacco Induced Dis. 11, 5 (2013).","journal-title":"Tobacco Induced Dis."},{"key":"79707_CR29","volume-title":"Landscape Indicators of Health in the Islamic Republic of Iran","author":"A Khosravi","year":"2009","unstructured":"Khosravi, A., Najafi, F., Rahbar, M. & Atefi, A. Landscape Indicators of Health in the Islamic Republic of Iran (Department of Health and Medical Education, Islamic Republic of Iran, Tehran, 2009)."},{"key":"79707_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ypmed.2006.03.001","volume":"42","author":"R Kelishadi","year":"2006","unstructured":"Kelishadi, R. et al. Smoking behavior and its influencing factors in a national-representative sample of Iranian adolescents: CASPIAN study. Prev. Med. 42, 423\u2013426 (2006).","journal-title":"Prev. Med."},{"key":"79707_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5603\/ARM.27689","volume":"79","author":"MH Boskabady","year":"2011","unstructured":"Boskabady, M. H. et al. The prevalence of smoking among the population in the city of Mashhad (north east of Iran) and pulmonary function tests among smokers. Adv. Respir. Med. 79, 21\u201325 (2011).","journal-title":"Adv. Respir. Med."},{"key":"79707_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12931-017-0643-5","volume":"18","author":"A Horner","year":"2017","unstructured":"Horner, A. et al. Altitude and COPD prevalence: Analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study. Respir. Res. 18, 162 (2017).","journal-title":"Respir. Res."},{"key":"79707_CR33","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/S0140-6736(05)67632-5","volume":"366","author":"AMB Menezes","year":"2005","unstructured":"Menezes, A. M. B. et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet 366, 1875\u20131881 (2005).","journal-title":"Lancet"},{"key":"79707_CR34","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.2147\/COPD.S113868","volume":"11","author":"SD Aaron","year":"2016","unstructured":"Aaron, S. D., Gershon, A. S., Gao, Y., Yang, J. & Whitmore, G. Influence of country-level differences on COPD prevalence. Int. J. Chronic Obstruct. Pulm. Dis. 11, 2305 (2016).","journal-title":"Int. J. Chronic Obstruct. Pulm. Dis."},{"key":"79707_CR35","doi-asserted-by":"publisher","first-page":"175346661986005","DOI":"10.1177\/1753466619860058","volume":"13","author":"S Sawalha","year":"2019","unstructured":"Sawalha, S. et al. The impact of comorbidities on mortality among men and women with COPD: Report from the OLIN COPD study. Ther. Adv. Respir. Dis. 13, 1753466619860058 (2019).","journal-title":"Ther. Adv. Respir. Dis."},{"key":"79707_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2296-14-11","volume":"14","author":"L Garc\u00eda-Olmos","year":"2013","unstructured":"Garc\u00eda-Olmos, L. et al. Comorbidity in patients with chronic obstructive pulmonary disease in family practice: A cross sectional study. BMC Fam. Pract. 14, 11 (2013).","journal-title":"BMC Fam. Pract."},{"key":"79707_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1155\/2012\/328460","volume":"19","author":"MR Maleki-Yazdi","year":"2012","unstructured":"Maleki-Yazdi, M. R. et al. The burden of illness in patients with moderate to severe chronic obstructive pulmonary disease in Canada. Can. Respir. J. 19, 319\u2013324 (2012).","journal-title":"Can. Respir. J."},{"key":"79707_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40248-015-0023-2","volume":"10","author":"R Dal Negro","year":"2015","unstructured":"Dal Negro, R., Bonadiman, L. & Turco, P. Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip. Respir. Med. 10, 24 (2015).","journal-title":"Multidiscip. Respir. Med."},{"key":"79707_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/jcm8040511","volume":"8","author":"FJ Triest","year":"2019","unstructured":"Triest, F. J. et al. Disease-specific comorbidity clusters in COPD and accelerated aging. J. Clin. Med. 8, 511 (2019).","journal-title":"J. Clin. Med."},{"key":"79707_CR40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1378\/chest.14-2434","volume":"148","author":"DM Mannino","year":"2015","unstructured":"Mannino, D. M. et al. Economic burden of COPD in the presence of comorbidities. Chest 148, 138\u2013150 (2015).","journal-title":"Chest"},{"key":"79707_CR41","first-page":"128","volume":"59","author":"K Matsumoto","year":"2011","unstructured":"Matsumoto, K. et al. Identifying unrecognized airflow obstruction in cases with lifestyle-related diseases using a data mining system with electronic medical records. Rinsho byori. Jpn. J. Clin. Pathol. 59, 128\u2013133 (2011).","journal-title":"Rinsho byori. Jpn. J. Clin. Pathol."},{"key":"79707_CR42","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1378\/chest.12-1899","volume":"144","author":"KB Yeatts","year":"2013","unstructured":"Yeatts, K. B. et al. Population-based burden of COPD-related visits in the ED: Return ED visits, hospital admissions, and comorbidity risks. Chest 144, 784\u2013793 (2013).","journal-title":"Chest"},{"key":"79707_CR43","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.2147\/COPD.S141988","volume":"12","author":"I Tuleta","year":"2017","unstructured":"Tuleta, I. et al. High prevalence of COPD in atherosclerosis patients. Int. J. Chronic Obstruct. Pulm. Dis. 12, 3047 (2017).","journal-title":"Int. J. Chronic Obstruct. Pulm. Dis."},{"key":"79707_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1164\/rccm.201510-2093OC","volume":"194","author":"D Chandra","year":"2016","unstructured":"Chandra, D. et al. Airflow limitation and endothelial dysfunction. Unrelated and independent predictors of atherosclerosis. Am. J. Respir. Crit. Care Med. 194, 38\u201347 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"79707_CR45","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4103\/ejb.ejb_64_19","volume":"13","author":"AS Gupta","year":"2019","unstructured":"Gupta, A. S., Rajesh, V. & James, P. Cardiovascular comorbidities associated with patients with chronic obstructive pulmonary disease\u2014A hospital-based study. Egypt J. Bronchol. 13, 591 (2019).","journal-title":"Egypt J. Bronchol."},{"key":"79707_CR46","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1080\/15412555.2018.1535580","volume":"15","author":"B Eriksson","year":"2018","unstructured":"Eriksson, B. et al. Pattern of cardiovascular comorbidity in COPD in a country with low-smoking prevalence: Results from two-population-based cohorts from Sweden. COPD J. Chronic Obstruct. Pulm. Dis. 15, 454\u2013463 (2018).","journal-title":"COPD J. Chronic Obstruct. Pulm. Dis."},{"key":"79707_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1586\/17476348.2013.814402","volume":"7","author":"EA Romme","year":"2013","unstructured":"Romme, E. A., Smeenk, F. W., Rutten, E. P. & Wouters, E. F. Osteoporosis in chronic obstructive pulmonary disease. Expert Rev. Respir. Med. 7, 397\u2013410 (2013).","journal-title":"Expert Rev. Respir. Med."},{"key":"79707_CR48","doi-asserted-by":"publisher","first-page":"e98013","DOI":"10.1371\/journal.pone.0098013","volume":"9","author":"M-K Breyer","year":"2014","unstructured":"Breyer, M.-K. et al. Prevalence of metabolic syndrome in COPD patients and its consequences. PLoS ONE 9, e98013 (2014).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79707-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79707-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79707-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:06:30Z","timestamp":1670033190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79707-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["79707"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-79707-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"4 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1548"}}